Rusan Pharma Pvt Ltd, an Indian pharmaceutical company specializing in addiction treatment and pain management, received USFDA GMP approval for its API facility in Gujarat. This achievement allows the company to expand its presence in the US market with a focus on niche APIs and signifies a commitment to quality and global standards.